Heartsciences closes non-dilutive financing to increase its cash runaway ahead of upcoming fda submission

Southlake, tx, sept. 12, 2024 (globe newswire) -- heart test laboratories, inc. d/b/a heartsciences (nasdaq: hscs; hscsw) (“heartsciences” or the “company”), an artificial intelligence (ai)-powered medical technology company focused on transforming ecgs/ekgs to save lives through earlier detection of heart disease, today announced the close of a non-dilutive financing, with $1.9 million in net proceeds.  the unsecured loan note has an 18-month maturity date and follows the recent 12-month extension of a $500,000 loan note to september 2025.
HSCS Ratings Summary
HSCS Quant Ranking